A carregar...
A new class of bronchodilator improves lung function in COPD: a trial with GSK961081
GSK961081 is a bifunctional molecule demonstrating both muscarinic antagonist and β-agonist activities. This was a 4-week, multicentre, randomised, double-blind, double-dummy, placebo and salmeterol controlled parallel group study. Doses ranging across three twice-daily doses and three once-daily do...
Na minha lista:
| Main Authors: | , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
European Respiratory Society
2013
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3787816/ https://ncbi.nlm.nih.gov/pubmed/23429913 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1183/09031936.00165712 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|